Abstract
It is well known that 17β-estradiol (E2) and 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) have important roles in bone metabolism. This study was undertaken to examine E2 regulation of 1,25(OH)2D3 receptor (VDR) expression and the biological action of 1,25(OH)2D3 in human osteoblast-like cells. When human osteosarcoma-derived osteoblast-like cells were treated with varying concentrations of E2, the VDR levels increased by up to 100% in a dose-dependent manner. VDR levels significantly increased at 10 nM E2 and this increase plateaued at 100 nM E2. E2-dependent increase of VDR was time dependent, plateauing, at 24 hours and was maintained for at least 48 hours in human osteoblast-like cells. Scatchard analysis showed that E2 increased the number of VDR (12.3±0.4 versus 26.5±0.3 fmol/mg protein; mean ±SE of three independent experiments) rather than the Kd (0.15±0.02 versus 0.16±0.01 nM; mean±SE of three independent experiments). Tamoxifen (50 nM), a specific competitor with E2, completely abolished the E2-induced increase of VDR. The levels of VDR mRNA (4.5 kb) from the cells increased in a dose-dependent manner after E2 treatment. With regard to the biological effects, E2 increased by 10–25% the inhibitory effect of 1,25(OH)2D3 on cell growth. However, E2 did not increase the stimulation of alkaline phosphatase activity by 1,25(OH)2D3. The present study suggests that E2 modulates the biological action of 1,25(OH)2D3 through VDR levels in bone cells.
Similar content being viewed by others
References
Lindsay R (1988) Sex steroids in the pathogenesis and prevention of osteoporosis. In: Liggs BL, Melton LJ III (eds) Osteoporosis etiology, diagnosis, and management. Raven Press, New York, p 333
Beato M (1989) Gene regulation by steroid hormones. Cell 56: 335–344
Komm BS, Terpening CM, Benz DJ, Graeme KA, Gallegos A, Kore M, Green GL, O'Malley BW, Haussler MR (1988) Estrogen binding, receptor mRNA, and biological responses in osteoblast-like osteosarcoma cells. Science 241:81–83
Eriksen EF Colvard DS, Berg NJ, Graham ML, Mann KG, Spelsberg TC, Riggs BL (1988) Evidence of estrogen receptors in normal human osteoblast-like cells. Science 241:84–86
Pensler JM, Rodosevich JA, Higbee R, Langman CB (1990) Osteoclast isolated from membranous bone in children exhibit nuclear estrogen receptors. J Bone Mineral Res 5:797–802
Ishibe M, Ishibe Y, Ishibashi T, Nojima T, Rosier RN, Puzas JE, Kaneda K (1994) Low content of estrogen receptors in human giant cell tumors of bone. Arch Orthop Trauma Surg 113: 106–109
Wronski TJ, Cintron M, Doherty AL, Dann LM (1988) Estrogen treatment prevents osteopenia and depresses bone turnover in ovariectomized rats. Endocrinology 123:681–686
Takano-Yamamoto T, Rodan GA (1990) Direct effects of 17β-estradiol on trabecular bone in ovariectomized rats. Proc Natl Acad Sci USA 87:2172–2176
Gray TK, Flynn TC, Gray KM, Nabell LM (1987) 17β-estradiol acts directly on the clonal osteoblastic cell line UMR 106. Proc Natl Acad Sci USA 84:6267–6271
Ernst M, Schmid C, Froesch ER (1988) Enhanced osteoblast proliferation and collagen gene expression by estradiol. Proc Natl Acad Sci USA 85:2307–2310
Ernst M, Heath JK, Rodan GA (1989) Estradiol effects on proliferation, messenger ribonucleic acid for collagen and insulin-like growth factor-I, and parathyroid hormone-stimulated adenylate cyclase activity in osteoblastic cells from calvariae and long bones. Endocrinology 125:825–833
Gray TK (1989) Estrogens and the skeleton; cellular and molecular mechanisms. J Steroid Biochem 34:285–287
Peck WA, Woods W (1988) The cells of bone. In: Riggs BL, Melton LJ III (eds), Osteoporosis etiology, diagnosis, and management, Raven Press, New York, p 1
Coccia PF, Krivit W, Cervenka J, Clawson C, Kersey JH, T.H.K., Nesbit ME, Ramsay NKC, Warkentin PI, Teitelbaum SL, Kahn AJ, Brown DM (1980) Successful bone marrow transplantation for infantile malignant osteoporosis. N Engl J Med 302: 701–708
Dokoh S, Donaldson CA, Haussler MR (1984) Influence of 1,25-dihydroxyvitamin D3 on cultured osteogenic sarcoma cells: correlation with 1,25-dihydroxyvitamin D3 receptors. Cancer Res 44:2103–2109
Franceschi RT, James WN, Zerlauth G (1985) 1α-25-dihydroxyvitamin D3 specific regulation of growth, morphology, and fibronectin in a human osteosarcoma, cell line. J Cell Physiol 123:401–409
Gallagher JC Goldgar D (1990) Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol. Ann Intern Med 113:649–655
Somjen D, Kaye AM, Harell A, Weisman Y (1989) Modulation by vitamin D of rat bone to gonadal steroids status, of the responsiveness. Endocrinology 125:1870–1876
Liel Y, Kraus S, Levy J, Shany S (1992) Evidence that estrogens modulate activity and increase the number of 1,25-dihydroxyvitamin D receptors in osteoblas-like cells (ROS 17/2.8). Endocrinology 130:2597–2601
Walters MR (1981) An estrogen-stimulated 1,25-dihydroxyvitamin D3 receptor in rat uterus. Biochem Biophys Res Commun 103:721–726
Levy J, Zuili I, Yankowitz N, Shany S (1984) Induction of cytosolic receptors for 1α,25 dihydroxyvitamin, D3 in the immature rat uterus by oestradiol. J Endocrinology 100:265
Duncan WE, Glass AR, Wray HL (1991) Estrogen regulation of the nuclear 1,25-dihydroxyvitamin D3 receptor in rat liver and kidney. Endocrinology 129:2318–2324
Escaleira MTF, Sonohara S, Brentani MM (1993) Sex steroids induced up-regulation of 1,25-(OH)2 vitamin, D3 receptors in T 47D breast cancer cells. J Steroid Biochem Mol Biol 45:257–263
Mahonen A, Pirskanen A, Pirskanen A Maenpaa PH (1991) Homologous and heterologous regulation of 1,25-dihydroxyvitamin D-3 receptor mRNA levels in human osteosarcoma cells. Biochim Biophys Acta, 1088:111–118
Sasaki T, Yagi T, Usui M, Matsuyama T, Nojima T (1986) Biological, functional and morphological characteristics, of human bone and soft tissue tumors in nude, mice. Hokkaido J Med Sci 61:257–270
Chen TL, Feldman D (1981) Regulation of 1,25-dihydroxyvitamin D3 receptors in cultured mouse bone cells. J Biol Chem 256:5561–5566
Nanes MS, Rubin J, Titus L, Hendy GN, Catherwood BD (1990) Interferon gamma inhibits the synthesis bone gla protein by a pretranslational mechanism. Endocrinology 127:588–594
Lowry OH (1955) Micromethods for the assay of enzyme. II: specific procedures. Alkaline phosphatase. Methods Enzymol 4:371–372
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
Chen TL, Cone CM, Morey-Holton E, Feldman D (1982), Glucocorticoid regulation of 1,25(OH)2-vitamin D3 receptors in cultured mouse bone cells. J Biol Chem 257:13564–13569
Chen TL, Cone CM, Morey-Holton E, Feldman D (1983) 1α,25-dihydroxyvitamin D3, receptors in cultured rat osteoblast-like cells. J Biol Chem 258:4350–4355
Chen TL, Haushka PV, Feldman D (1986) Dexamethasone increases 1,25-dihydroxyvitamin D3 receptor levels and augments bioresponses in rat osteoblast-like cells. Endocrinology 118: 1119–1126
Somjen D, Weisman Y, Harell A, Berger E, Kaye AM (1989) Direct and sex-specific stimulation by sex steroids of creatine kinase and DNA synthesis. Proc Natl Acad Sci USA 86:3361–3365
Keeting EK, Scott RE, Colvard DS, Han IK, Spelberg TC, Riggs BL (1991) Lack of direct effect of estrogen on proliferation and differentiation of normal human osteoblast-like cells. J Bone Miner Res 6:297–304
Canalis E (1983) Effect of hormones and growth factors on alkaline phosphatase activity and collagen synthesis in cultured rat calvariae. Metabolism 32:14–20
Ramp WK, Baker RL (1985) 1,25-Dihydroxyvitamin D3 decreases alkaline phosphatase activity in cultures of embryonic chick tibiae (42029) Proc Soc Exp Biol Med 178:437–442
Majeska RJ, Rodan GA (1982) The effect of 1,25-(OH)2-D3 on alkaline phosphatase activity in osteoblasts by osteosarcoma cell lines. J Biol Chem 257:3362–3365
Manolagas SC, Spiess YH, Burton DW, Deftos LJ, (1983) Mechanism of action of 1,25-dihydroxyvitamin D3-induced stimulation of alkaline phosphatase in cultured osteoblast-like cells. Mol Cell Endocrinol 333:27–36
Kumegawa M, Ikeda E, Tanaka S, Haneji T, Yora T, Sakagishi Y, Minami N, Hiramatsu M (1984) The effects of prostaglandin E2, parathyroid hormone, 1,25 dihydroxycholecalciferol, and cyclic nucleotide analogs on alkaline phosphatase activity in osteoblastic cells. Calcif Tissue Int, 36:72–76
Fritsch J, Grosse B, Lieberherr M, Balsan S (1985) 1,25-Dihydroxyvitamin D3 is required for growth-independent expression of alkaline phosphatase in cultured rat osteoblasts. Calcif Tissue Int 37:639–645
Pritchard JA, MacDonald PC, Gant NF (1985) Williams obstetrics. Appleton-Century-Crofts, Norwalk, CT
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ishibe, M., Nojima, T., Ishibashi, T. et al. 17β-Estradiol increases the receptor number and modulates the action of 1,25-dihydroxyvitamin D3 in human osteosarcoma-derived osteoblast-like cells. Calcif Tissue Int 57, 430–435 (1995). https://doi.org/10.1007/BF00301946
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00301946